Asymmetric Dimethylarginine Levels and Its Correlation to Cerebral Blood Flow in Children with Sickle Cell Anemia
- 16 Downloads
Asymmetric dimethylarginine (ADMA) level may play a role in the pathogenesis of cerebrovascular stroke in Children with Sickle Cell Anemia (SCA). To assess the plasma level of ADMA in children with SCA and its correlation to cerebral blood flow. This is a cross sectional study was carried out on 30 children with homozygous SCA under follow up in the Out Patients Clinic, Pediatric Department at Tanta University Hospital and 30 healthy children as a control group. Both groups had undergone the following investigations: Complete blood count, lactate dehydrogenase enzyme, and plasma level of ADMA by a commercial ADMA ELISA Kit. Trans-cranial Doppler were done for both groups. ADMA plasma level was significantly higher in-patient group in comparison to the control group (p < 0.001), with a mean value 1.43 ± 0.20 μmol/l, 0.48 ± 0.16 μmol/l respectively. The time-averaged mean maximum velocities for middle cerebral artery, anterior cerebral artery, inferior cerebral artery and posterior cerebral artery were significantly different between patient and control group, p < 0.05. Trans-cranial Doppler data revealed that, 86.7% of patients have low velocity (< 70 cm/s) and 13.3% having very low velocity (< 10 cm/s) while control group have normal velocity. There was a significant negative correlation between ADMA plasma levels and cerebral blood flow. Elevated ADMA levels may have a role in the pathogenesis of the decreased cerebral blood flow in children with SCA.
KeywordsSickle cell anemia TCD Asymmetric dimethyl arginine
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all the guardians of children participants included in the study.
- 4.Morris CR, Kim HY, Klings ES, Wood J, Porter JB, Trachtenberg F, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Hassell K, Taher A, Neufeld EJ, Thompson AA, Larkin S, Suh JH, Vichinsky EP, Kuypers FA (2015) Thalassemia clinical research network. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassemia. Br J Haematol 169(6):887–898CrossRefGoogle Scholar
- 7.Laranja D, Gomes Rodrigues G, Adegoke S, Campos RM, Pellegrini Braga JP, Figueiredo MS, Silva GS (2017) Patients with sickle cell disease are frequently excluded from the benefits of transcranial Doppler screening for the risk of stroke despite extensive and compelling evidence. Arq Neuro Psiquiatr 75(1):15–19CrossRefGoogle Scholar
- 8.Kotz S, Balakrishnan N, Read CB, Vidakovic B (2006) Encyclopedia of statistical sciences, 2nd edn. Wiley, HobokenGoogle Scholar
- 9.Kirkpatrick LA, Feeney BC (2013) A simple guide to IBM SPSS statistics for version 20.0. Wadsworth, Cengage Learning, BelmontGoogle Scholar
- 11.Senbanjo IO, Oshikoya KA, Salisu M, Diaku-Akinwumi IN (2016) Head circumference of children with sickle cell disease in Lagos. Niger Pan Afr Med J 25:4Google Scholar
- 13.Czarnecka A, Milewski K, Zielińska M (2017) Asymmetric dimethylarginine and hepatic encephalopathy: cause, effect or association? Neuro Chem Res 42(3):750–761Google Scholar
- 17.Visser M, Davids M, Verberne HJ, Kok WE, Tepaske R, Cocchieri R, Kemper EM, Teerlink T, Jonker MA, Wisselink W, deMol BA, vanLeeuwen PA (2014) Nutrition before, during, and after surgery increases the arginine: asymmetric dimethylarginine ratio and relates to improved myocardial glucose metabolism: a randomized controlled trial. Am J Clin Nutr 99(6):1440–1449CrossRefGoogle Scholar